Salubris Pharmaceuticals Celebrates Ribbon Cutting of New Research & Development Lab

Salubris Pharmaceuticals Celebrates Ribbon Cutting of New Research & Development Lab

SalubrisPRPhotoGaithersburg, MD-May 1, 2017—Salubris Pharmaceuticals opened their new research & development laboratory today at 10:30 AM at 45 West Watkins Road in Gaithersburg, Maryland. The new R&D Center is a subsidiary and will operate as Salubris Biotherapeutics.

Celebrating the arrival of one of Fortune Magazine’s Top 200 Asia Firms into Montgomery County were:

·     The Honorable Boyd K. Rutherford, Maryland Lieutenant Governor

·     The Honorable Jud Ashman, City of Gaithersburg Mayor

·     The Honorable Isiah (Ike) Leggett,  Montgomery County Executive

·     Kevin Ye, CEO, Salubris Pharmaceuticals

Scheer Partners represented Salubris Pharmaceuticals in locating, negotiating and the build-out for this new facility. Henry Bernstein represented the tenant.

Salubris Pharmaceuticals Co., Ltd. engages in the research and development, manufacture, marketing, distribution, and service of pharmaceutical and healthcare products. This is their first facility in the US and will focus on cancer and cardiovascular therapeutics.

No Comments

Post A Comment